Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 15:36:42 UTC
Update Date2021-09-26 23:10:53 UTC
HMDB IDHMDB0255769
Secondary Accession NumbersNone
Metabolite Identification
Common NameIlginatinib
DescriptionSCHEMBL22806851 belongs to the class of organic compounds known as aminopyrazines. These are organic compounds containing an amino group attached to a pyrazine ring. Based on a literature review very few articles have been published on SCHEMBL22806851. This compound has been identified in human blood as reported by (PMID: 31557052 ). Ilginatinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Ilginatinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC21H20FN7
Average Molecular Weight389.438
Monoisotopic Molecular Weight389.176421835
IUPAC NameN2-[1-(4-fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N6-(pyrazin-2-yl)pyridine-2,6-diamine
Traditional NameN2-[1-(4-fluorophenyl)ethyl]-4-(1-methylpyrazol-4-yl)-N6-(pyrazin-2-yl)pyridine-2,6-diamine
CAS Registry NumberNot Available
SMILES
CC(NC1=CC(=CC(NC2=NC=CN=C2)=N1)C1=CN(C)N=C1)C1=CC=C(F)C=C1
InChI Identifier
InChI=1S/C21H20FN7/c1-14(15-3-5-18(22)6-4-15)26-19-9-16(17-11-25-29(2)13-17)10-20(27-19)28-21-12-23-7-8-24-21/h3-14H,1-2H3,(H2,24,26,27,28)
InChI KeyUQTPDWDAYHAZNT-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as aminopyrazines. These are organic compounds containing an amino group attached to a pyrazine ring.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassDiazines
Sub ClassPyrazines
Direct ParentAminopyrazines
Alternative Parents
Substituents
  • Secondary aliphatic/aromatic amine
  • Halobenzene
  • Fluorobenzene
  • Aminopyridine
  • Aminopyrazine
  • Imidolactam
  • Benzenoid
  • Pyridine
  • Monocyclic benzene moiety
  • Aryl halide
  • Aryl fluoride
  • Heteroaromatic compound
  • Pyrazole
  • Azole
  • Azacycle
  • Secondary amine
  • Organic nitrogen compound
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Organonitrogen compound
  • Organofluoride
  • Organohalogen compound
  • Amine
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.17ALOGPS
logP3.38ChemAxon
logS-4.2ALOGPS
pKa (Strongest Acidic)11.89ChemAxon
pKa (Strongest Basic)4.93ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area80.55 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity122.5 m³·mol⁻¹ChemAxon
Polarizability41.48 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+194.43730932474
DeepCCS[M-H]-192.07930932474
DeepCCS[M-2H]-226.08530932474
DeepCCS[M+Na]+201.20930932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
IlginatinibCC(NC1=CC(=CC(NC2=NC=CN=C2)=N1)C1=CN(C)N=C1)C1=CC=C(F)C=C14818.8Standard polar33892256
IlginatinibCC(NC1=CC(=CC(NC2=NC=CN=C2)=N1)C1=CN(C)N=C1)C1=CC=C(F)C=C13456.2Standard non polar33892256
IlginatinibCC(NC1=CC(=CC(NC2=NC=CN=C2)=N1)C1=CN(C)N=C1)C1=CC=C(F)C=C13643.4Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Ilginatinib,1TMS,isomer #1CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(NC2=CN=CC=N2)=N1)[Si](C)(C)C3519.8Semi standard non polar33892256
Ilginatinib,1TMS,isomer #1CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(NC2=CN=CC=N2)=N1)[Si](C)(C)C3438.0Standard non polar33892256
Ilginatinib,1TMS,isomer #1CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(NC2=CN=CC=N2)=N1)[Si](C)(C)C5063.3Standard polar33892256
Ilginatinib,1TMS,isomer #2CC(NC1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C)=N1)C1=CC=C(F)C=C13456.5Semi standard non polar33892256
Ilginatinib,1TMS,isomer #2CC(NC1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C)=N1)C1=CC=C(F)C=C13443.7Standard non polar33892256
Ilginatinib,1TMS,isomer #2CC(NC1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C)=N1)C1=CC=C(F)C=C14686.5Standard polar33892256
Ilginatinib,2TMS,isomer #1CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C)=N1)[Si](C)(C)C3388.3Semi standard non polar33892256
Ilginatinib,2TMS,isomer #1CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C)=N1)[Si](C)(C)C3377.3Standard non polar33892256
Ilginatinib,2TMS,isomer #1CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C)=N1)[Si](C)(C)C4393.2Standard polar33892256
Ilginatinib,1TBDMS,isomer #1CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(NC2=CN=CC=N2)=N1)[Si](C)(C)C(C)(C)C3741.4Semi standard non polar33892256
Ilginatinib,1TBDMS,isomer #1CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(NC2=CN=CC=N2)=N1)[Si](C)(C)C(C)(C)C3627.7Standard non polar33892256
Ilginatinib,1TBDMS,isomer #1CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(NC2=CN=CC=N2)=N1)[Si](C)(C)C(C)(C)C5121.8Standard polar33892256
Ilginatinib,1TBDMS,isomer #2CC(NC1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C(C)(C)C)=N1)C1=CC=C(F)C=C13632.0Semi standard non polar33892256
Ilginatinib,1TBDMS,isomer #2CC(NC1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C(C)(C)C)=N1)C1=CC=C(F)C=C13565.2Standard non polar33892256
Ilginatinib,1TBDMS,isomer #2CC(NC1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C(C)(C)C)=N1)C1=CC=C(F)C=C14719.2Standard polar33892256
Ilginatinib,2TBDMS,isomer #1CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C(C)(C)C)=N1)[Si](C)(C)C(C)(C)C3754.9Semi standard non polar33892256
Ilginatinib,2TBDMS,isomer #1CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C(C)(C)C)=N1)[Si](C)(C)C(C)(C)C3735.5Standard non polar33892256
Ilginatinib,2TBDMS,isomer #1CC(C1=CC=C(F)C=C1)N(C1=CC(C2=CN(C)N=C2)=CC(N(C2=CN=CC=N2)[Si](C)(C)C(C)(C)C)=N1)[Si](C)(C)C(C)(C)C4473.5Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Ilginatinib GC-MS (Non-derivatized) - 70eV, Positivesplash10-00di-2209000000-bdbe88d5a84e718667452021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Ilginatinib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID64880076
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound75236651
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]